Walgreens is Spending Too Much on Primary Care

Walgreens’ core business is struggling as public and private healthcare payors push for lower healthcare spending, Seeking Alpha reports.

Since its troubles began to surface four years ago, Walgreens has gradually lost its long-term backers, mirrored in the 52% decline in share price.

The company is spending aggressively on primary care at the expense of the health of its balance sheet.

The opioid settlement was a severe setback for Walgreens and its shareholders in FQ1, costing the company $5.9 billion and leading to an operating loss of $6.2 billion. Read more.

Total
0
Shares
Related Posts
Read More

The Private Equity Bet on Healthcare

A record amount of private equity flooded into the healthcare sector in 2021. This year, investors seem to be proceeding with a little more caution. Even so, the investment is a major development in how healthcare gets financed and the makeup of the sector’s ownership interest.